生物医药
Search documents
英矽智能获纳入恒生综合指数成份股
Xin Lang Cai Jing· 2026-02-20 00:55
英矽智能(03696)公布,公司已获恒生指数有限公司选择并将被纳入恒生综合指数的成份股,自2026 年3月9日起生效。 获纳入恒生综合指数成份股后,公司股份预计将符合沪港通及深港通交易的纳入标准。沪港通及深港通 是中国香港与中国内地的资本市场投资者之间的股票交易与投资的渠道。 董事会认为,获纳入恒生综合指数成份股反映了国际资本市场对公司行业地位、业务表现及价值的高度 认可。此举预期将进一步提升公司股票流动性,透过多元化的股东结构扩大投资者基础,并促进公司长 远发展。 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 英矽智能(03696)公布,公司已获恒生指数有限公司选择并将被纳入恒生综合指数的成份股,自2026 年3月9日起生效。 获纳入恒生综合指数成份股后,公司股份预计将符合沪港通及深港通交易的纳入标准。沪港通及深港通 是中国香港与中国内地的资本市场投资者之间的股票交易与投资的渠道。 责任编辑:卢昱君 责任编辑:卢昱君 董事会认为,获纳入恒生综合指数成份股反映了国际资本市场对公司行业地位、业务表现及价值的高度 认可。此举预期 ...
哈尔滨深圳联动激活科技“富矿”
Xin Lang Cai Jing· 2026-02-19 21:59
作为这场联动的核心载体,从2019年开始建设的哈尔滨新区深圳(哈尔滨)产业园区(简称"深哈产业 园"),不仅是一个地理空间,更是一片制度创新、要素聚合、产业共生的试验沃土,孕育出智慧农 业、装备制造、生物医药等一个个产业新苗,成为跨区域科创协同、培育发展新动能的典型样本。 (来源:黑龙江日报) 南北携手推动技术成果落地 转自:黑龙江日报 走进深哈产业园科创总部,现代化的楼宇间涌动着创新热潮。近百家蒸蒸日上的科技型企业,凸显园区 跨区域合作的切实成效。 □新华社记者 强勇 徐凯鑫 王祚 "我们的无人机,是在黑土地上一遍遍'飞'出来的。"指着眼前一架畅销国内外的农业无人机,黑龙江惠 达科技股份有限公司副总经理初海波自豪地向记者介绍公司独立研发的无人机。 在中国区域协调发展的大棋局中,一次跨越2800公里的创新牵手,持续迸发出强劲活力——哈尔滨和深 圳,两座禀赋迥异的城市,正合力探索新质生产力发展新路径。 "深哈产业园的大力帮扶加上黑龙江丰富的应用场景,让我们找到了技术价值最大化的实现路径。"初海 波说。 深哈产业园投资开发有限公司总经理蔡庆臣将这种模式概括为"科研端(哈尔滨)+市场端(深圳)"的 整合。 深哈产业 ...
千亿巨头,大举加仓!
Zhong Guo Ji Jin Bao· 2026-02-19 12:11
Core Insights - Hillhouse Capital's HHLR Advisors revealed its Q4 2025 holdings, showing a significant portfolio adjustment with a total market value of $3.104 billion, a 24% decrease from the previous quarter [2][3]. Group 1: Portfolio Adjustments - HHLR Advisors increased its positions in Alibaba and Pinduoduo, marking them as core holdings, while also initiating a position in the iShares Bitcoin ETF [2][3][8]. - The top ten holdings include seven Chinese concept stocks, which account for 92% of the portfolio, focusing on internet e-commerce, biomedicine, and fintech sectors [3][6]. Group 2: Major Holdings - Pinduoduo remains the largest holding, with shares increasing from 8.59 million to 10.72 million, raising its market value from $1.136 billion to $1.216 billion, now representing 39% of the portfolio [5][6]. - Alibaba, the second-largest holding, saw its shares rise from 3.289 million to 5.43 million, increasing its market value from $588 million to $796 million, now comprising 26% of the portfolio [5][6]. Group 3: Reductions and Exits - HHLR Advisors significantly reduced its holdings in Futu and Webull, with Futu's shares nearly halved from 3.238 million to 1.63 million, and Webull's shares almost fully liquidated [9][10]. - The firm completely exited positions in Baidu, NetEase, and several other non-core stocks [9][10].
高人预测:如不出意外,春节过后,社会上会出现5种“现象”
Sou Hu Cai Jing· 2026-02-19 11:46
Group 1 - The first phenomenon observed post-Spring Festival is that many individuals experience a financial shortfall, as holiday expenses often exceed their budget, leading to reliance on credit options [3][4][6][8] - The second phenomenon is the increasing difficulty in job hunting after the Spring Festival, with a projected 12.7 million graduates in 2026, creating a highly competitive job market where employers are more selective [10][12][14] - The third phenomenon is a noticeable trend towards consumption downgrade, with nearly 60% of residents preferring to save more rather than spend, indicating a shift in consumer behavior towards more practical spending [16][18][20] Group 2 - The fourth phenomenon is a growing desire for stability in life, as evidenced by the high competition for civil service positions, with an average of 100 applicants per job, reflecting a preference for secure employment over higher salaries [22][23][25][28] - The fifth phenomenon is a decline in social obligations and "face consumption," with individuals reassessing the value of traditional gift-giving and opting for more practical and budget-friendly choices [30][32][34]
高瓴大调仓:中概股仍是“心头好” 对科技保持关注
Shang Hai Zheng Quan Bao· 2026-02-19 07:57
Core Insights - HHLR Advisors, a fund management platform under Hillhouse Capital, reported its US stock holdings as of the end of Q4 2025, with a significant focus on Chinese concept stocks, which accounted for 92% of its portfolio [1][2]. Group 1: Holdings Overview - HHLR holds a total of 33 US-listed companies, with its top ten holdings including Pinduoduo, Alibaba, BeiGene, Futu Holdings, Legend Biotech, Arrivent Biopharma, Beike, Webull Corp, Cytek Biosciences, and Clearwater Analytics, with seven of these being Chinese concept stocks [2][4]. - The market value of HHLR's holdings in Pinduoduo reached approximately $1.22 billion, with a total of 10.72 million shares, reflecting an increase of 2.13 million shares from the previous quarter [4][5]. - Alibaba's holdings increased from 3.29 million shares to 5.43 million shares, with the market value rising from $588 million to $796 million, making it the second-largest holding in HHLR's portfolio [7]. Group 2: Trading Activities - HHLR significantly increased its positions in Pinduoduo and Alibaba while reducing its holdings in Futu Holdings and Webull Corp, with Futu's shares decreasing by nearly 50% from 3.24 million to 1.63 million [5][7]. - The firm also completely exited positions in several companies, including NetEase, Baidu, Manbang Group, Donghai Group, and Bright Scholar [7]. - HHLR made a small purchase of Google shares, ending the quarter with 7,300 shares, while also acquiring 11,300 shares of TSMC, valued at approximately $3.43 million [8][10]. Group 3: Market Context - The increase in holdings of Pinduoduo and Alibaba aligns with similar moves by other major private equity firms, indicating a collective bullish sentiment towards these stocks despite Pinduoduo's revenue growth slowing to 9% year-over-year [5]. - The AI sector is highlighted as a key area of interest, with ongoing developments in various subfields, suggesting that companies in this space may present significant investment opportunities [8].
因地制宜发展新质生产力丨跨越2800公里的牵手:哈尔滨深圳联动激活科技“富矿”
Xin Hua Wang· 2026-02-19 06:55
南北携手推动技术成果落地 在中国区域协调发展的大棋局中,一次跨越2800公里的创新牵手,持续迸发出强劲活力——哈尔滨和深圳,两座禀赋迥异的城市,正合力探 索新质生产力发展新路径。 作为这场联动的核心载体,从2019年开始建设的哈尔滨新区深圳(哈尔滨)产业园区(简称"深哈产业园"),不仅是一个地理空间,更是一 片制度创新、要素聚合、产业共生的试验沃土,孕育出智慧农业、装备制造、生物医药等一个个产业新苗,成为跨区域科创协同、培育发展新动 能的典型样本。 走进深哈产业园科创总部,现代化的楼宇间涌动着创新热潮。近百家蒸蒸日上的科技型企业,凸显园区跨区域合作的切实成效。 "我们的无人机,是在黑土地上一遍遍'飞'出来的。"指着眼前一架畅销国内外的农业无人机,黑龙江惠达科技股份有限公司副总经理初海波 自豪地向记者介绍公司独立研发的无人机。 数据显示,截至2025年底,深哈产业园科创总部累计注册企业717家,注册资本242亿元。其中,已投入运营的项目一期企业入驻率超90%, 累计营收超170亿元。 整合两地优势持续激发潜能 广袤的黑土地为智能农机提供了绝佳的试验场。成立以来,惠达科技将深圳积累的物联网、人工智能、北斗导航等技 ...
Cell:赵祥团队等通过组氨酸扫描调制TCR等机械力感应受体敏感性,为更安全的TCR-T细胞疗法奠定基础
生物世界· 2026-02-19 02:20
Core Viewpoint - The article discusses advancements in T Cell Receptor (TCR) therapy for solid tumors, highlighting the challenges in developing effective and specific TCRs while addressing the potential for off-target toxicity [3]. Group 1: Research Findings - A study published in the journal Cell introduces a histidine scanning engineering strategy that significantly enhances the activation efficacy of mechanosensory receptors like TCRs [4]. - The research demonstrates that histidine scanning can identify hotspots that form additional catch bonds, allowing for the creation of a TCR library aimed at low-affinity, high-efficacy variants without off-target or on-target toxicity [6]. Group 2: Implications for Therapy - The findings provide a universal engineering method for low-affinity, high-efficacy TCRs, enabling the design of TCR libraries without structural constraints [8]. - The histidine scanning approach has broader applications in other mechanosensory ligand-receptor systems, potentially impacting various immunotherapy strategies [8].
美国FDA局长抱怨:美国在早期药物研发方面正落后于中国
Xin Lang Cai Jing· 2026-02-19 00:28
当地时间2月18日,在接受美国消费者新闻与商业频道(CNBC)采访时,马卡里特别指出了导致美国 在早期药物试验方面落后的三大瓶颈。 这些瓶颈包括医院合同签订以及伦理审查和审批,他称这两项流程"繁琐冗长,导致我们在与那些进展 迅速的国家竞争时处于劣势"。他还认为,提交和获得研究性新药(IND)申请的流程也存在问题,企 业需要提交IND申请才能对产品进行人体试验。 "我们接手的是一个烂摊子,"马卡里直接把"锅"甩锅了拜登政府,声称美国在2024年开展的I期临床试 验方面远远落后于中国。 【文/观察者网 熊超然】美国食品药品管理局(FDA)局长马蒂·马卡里(Marty Makary)日前警告称, 在早期药物研发方面,美国正落后于中国,并呼吁进行改革,以简化新疗法临床试验的启动流程。 如今,中国正迅速转型为全球创新强国。而与此同时,美国决策者一直面临着采取措施促进国内创新的 压力。 来自咨询机构Global Data和金融服务机构摩根士丹利的数据显示,中国目前开展的临床试验数量超过美 国,新药获批数量占全球近三分之一,预计到2040年将占美国FDA批准药物总数的35%。 各地正在建设的生命科学实验室/研发中心面积,按 ...
高瓴 大调仓
Shang Hai Zheng Quan Bao· 2026-02-18 14:42
Group 1: Core Insights - HHLR Advisors, a fund management platform under Hillhouse Capital, reported its US stock holdings as of the end of Q4 2025, with a focus on Chinese concept stocks, which constitute 92% of its portfolio [1][2]. - The top ten holdings of HHLR include Pinduoduo, Alibaba, BeiGene, Futu Holdings, Legend Biotech, Arrivent Biopharma, Beike, Webull Corp, Cytek Biosciences, and Clearwater Analytics, with seven of these being Chinese concept stocks [2][4]. Group 2: Investment Actions - HHLR significantly increased its holdings in Pinduoduo and Alibaba, while reducing its positions in Futu Holdings and Webull, indicating a strategic shift towards e-commerce leaders, biomedicine, and technology sectors [1][5][7]. - As of the end of Q4 2025, HHLR held 10.72 million shares of Pinduoduo, an increase of 2.13 million shares from the previous quarter, and 5.43 million shares of Alibaba, up by 2.14 million shares [5][7]. Group 3: Market Trends and Sector Focus - The investment in Pinduoduo aligns with similar moves by other major private equity firms, suggesting a consensus on the stock's potential despite a recent decline in its share price [5]. - HHLR also showed interest in technology stocks, acquiring shares in Google and TSMC, reflecting a broader trend of investment in AI and semiconductor sectors, which are seen as having significant growth potential [8][10].
国新证券:ESG信息披露全面升级 专项应用指南精准补
Xin Lang Cai Jing· 2026-02-18 03:56
Core Insights - The China Securities Regulatory Commission (CSRC) has guided the Shanghai, Shenzhen, and Beijing stock exchanges to release disclosure guidelines on three environmental topics: "pollutant emissions," "energy utilization," and "water resource utilization," further improving ESG information disclosure rules for listed companies [2] Group 1: ESG Disclosure Guidelines - The release of the guidelines addresses key disclosure pain points for high energy-consuming and high-emission industries, specifying calculation methods, data sources, and disclosure formats for specific indicators [3] - The year 2025 is identified as a critical transition year for ESG information disclosure in China's A-share market, moving from voluntary to mandatory disclosure [3] - The new ESG disclosure regulations achieve three core breakthroughs: expanding the mandatory disclosure scope, systematizing disclosure content, and aligning international standards with local innovations [3] Group 2: Industry-Specific Strategies - Different industries require differentiated strategies for ESG disclosure due to variations in business characteristics, environmental impact, and social relevance [4] - High energy-consuming industries focus on carbon management and detailed disclosures on pollutants and energy use, while manufacturing emphasizes supply chain data management [4] - Emerging industries like renewable energy and AI must integrate innovation with sustainability, focusing on technology research and data ethics, respectively [4] Group 3: Future Implications - The expansion of mandatory disclosure and continuous improvement of standards will optimize the ESG ecosystem in the A-share market [4] - ESG information disclosure will become a crucial tool for companies to enhance core competitiveness, reduce financing costs, and connect with international capital markets [4] - This shift will support China's dual carbon goals and high-quality development by directing capital market resources towards sustainable development [4]